drugset / Trial / NCT06078202
A Study to Assess the Relative Bioavailability of Three Immediate-Release Tablet Formulations of ABBV-903 in Healthy Adult Volunteers
RandomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to evaluate the relative bioavailability of three immediate-release table formulations of ABBV-903 under fasting conditions in healthy volunteers, and to evaluate the effect of food on the pharmacokinetics of three immediate-release table formulations of ABBV-903.
Timeline
- Start
- 2024-12-01
- Primary completion
- 2025-01-31
- Completion
- 2025-01-31
Outcome
Outcome not reported
Stopped (Business): “Strategic considerations”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-903 | Unknown | — | Oral |
Indications
No indication recorded.